Last updated: 11/03/2018 22:45:18

In Vivo investigation of initial stages of enamel erosion

GSK study ID
204739
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Completed
Completed
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Study to investigate the initial stages of enamel erosion in vivo
Trial description: This exploratory study is designed to help develop a clinical model to measure the earlier stages of dietary acid medicated enamel loss. The study will use fluoride as positive control to explore the validity of this design.
Primary purpose:
Basic Science
Trial design:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Allocation:
Randomized
Primary outcomes:

Change from pre-acid challenge (baseline) tooth impression grading score immediately following an acid challenge

Timeframe: Baseline, 30 minutes post dietary acid challenge

Secondary outcomes:

Change from pre-acid challenge (baseline) tooth impression grading score following 2 hours post acid challenge.

Timeframe: Baseline, 2 hours post acid challenge

Change from pre-acid challenge (baseline) tooth impression grading score following 4 hours post acid challenge

Timeframe: Baseline, 4 hours post acid challenge

Change from pre-acid challenge (baseline) tooth impression grading score following 7 hours post acid challenge

Timeframe: Baseline, 7 hours post acid challenge

Change from Baseline of Salivary Calcium Concentration at 30 mins post dietary acid challenge

Timeframe: Baseline, 30 mins post dietary acid challenge

Change from Baseline of Salivary Calcium Concentration 7 hours post dietary acid challenge

Timeframe: Baseline, 7 hours post dietary acid challenge

Change from Baseline of pH Measurement at 30 mins post dietary acid challenge

Timeframe: Baseline, 30 mins post dietary acid challenge

Change from baseline of pH measurement 7 hours post dietary acid challenge

Timeframe: Baseline, 7 hours post dietary acid challenge

Change from baseline in buffering capacity at 30 mins post dietary acid challenge

Timeframe: Baseline, 30 mins post dietary acid challenge

Change from baseline in buffering capacity 7 hours post dietary acid challenge

Timeframe: Baseline, 7 hours post dietary acid challenge

Interventions:
Other: Sodium fluoride + potassium nitrate
Other: Potassium nitrate
Enrollment:
30
Observational study model:
Not applicable
Primary completion date:
2015-06-11
Time perspective:
Not applicable
Clinical publications:
Not applicable
Medical condition
tooth erosion
Product
potassium nitrate, potassium nitrate/sodium fluoride, sodium fluoride
Collaborators
Not applicable
Study date(s)
October 2015 to November 2015
Type
Interventional
Phase
Not applicable

Participation criteria

Sex
Female & Male
Age
18 - 70 years
Accepts healthy volunteers
Yes
  • Demonstrates understanding of the study procedures, restrictions and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
  • Aged at least 18 years
  • Pregnant or breast feeding women
  • Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
Bristol, United Kingdom, BS1 2LY
Status
Study Complete

Study documents

Statistical analysis plan
Available language(s): English
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
Protocol
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Results posted on ClinicalTrials.gov

Recruitment status
Completed
Actual primary completion date
2015-06-11
Actual study completion date
2015-06-11

Plain language summaries

Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

Additional information about the trial

Additional information
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website